Basic Science high dose VitD3 were significantly decreased (P < 0.05); the activity of caspase-3, TNF-a, CD40 in all drug intervention groups were significantly decreased (P < 0.01); no significant difference in mRNA expression was found between TNBS group and all drug intervention groups. Rats in continuous high dose VitD3 group had hyperealcemia and serum level of creatinine was significantly increased in continuous high dose VitD3 group when compared with the other groups (P < 0.05). Conclusions: VitD3 can alleviate TNBS induced experimental colitis by regulating T cell immunity. P011 The impact of omentectomy on the severity of colitis and adipocytokine expression S. Yapali1 *, N. Oruc1 , C. Yenisey2 , M. Sezak3,4 , N.G. Ceri5 , O. Ozutemiz1 . 1 Ege University, School of Medicine, Gastroenterology, Izmir, Turkey, 2 Adnan Menderes University, School of Medicine, Biochemistry, Aydin, Turkey, 3 Ege Universit, School of Medicine, Pathology, Izmir, Turkey, 4 Ege University, School of Medicine, Pathology, Izmir, Turkey, 5 Adnan Menderes University, School of Medicine, Anatomy, Aydin, Turkey Background: Regarding the unidentified role of omental adipose tissue on intestinal inflammation, we hypothesized that complete removal of omentum may alter the severity of intestinal inflammation by changing cytokine and adipokine expression. We aimed to determine whether removal of omentum has any impact on the severity of colitis and the expression of cytokines and adipokines in an experimental model of trinitrobenzene sulphonic acid (TNBS) colitis induced after 6 months following omentectomy. Methods: Forty Wistar albino rats (20 M, 20 F) were divided into two groups. Group A (n = 20) underwent laparotomy and Group B (n = 20) underwent sham laparatomy without omentectomy. After 6 months following omentectomy, induction of colitis was performed by a single intracolonic administration of 0.25ml of 30% ethanol (V/V) containing 30 mg of 2,4,6TNBS. Control groups received 0.25 ml of vehicle (30% ethanol) with a similar method. Rats were divided into four groups: 1. Omentectomy & TNBS colitis; 2. Sham operated & TNBS colitis; 3. Omentectomy & ethanol; 4. Sham operated & ethanol. Distal colon and mesenteric fat tissue were removed for histological and biochemical assessments. Myeloperoxidase (MPO) activity, tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-18, were determined in colonic tissue homogenates by enzyme-linked immune sorbent assay (ELISA). Leptin and adiponectin levels were determined both in colonic and mesenteric fat tissue homogenates by ELISA. Expression of adipocytokines and severity of colitis were compared between the groups. Results: Macroscopic and histologic scoring of colitis tended to be higher in rats who underwent omentectomy and administered TNBS, the severity of colitis and MPO levels were not significantly altered with omentectomy. TNF-alpha (p = 0.006), IL-18 (p = 0.002) and adiponectin (p = 0.004) levels were significantly higher in Group 1 than those in Group 2. Omentectomy did not alter colonic leptin levels significantly. Moreover, mesenteric adipocytokine levels did not change significantly between the groups. Conclusions: Omentectomy led to significantly increased TNF-alpha, IL-18 and adiponectin levels that was accompanied by an increased tendency of colonic damage. The effects of increased cytokines on microscopic and histological findings may be a subsequent event. Removal of omental adipose tissue might also enhance dysregulation of mesenteric adipocytokine expression. This is the first study investigating long-term effects of omentectomy in an experimental model of colitis and S69 demonstrating that omentum keeps the novel protective role in intestinal inflammation. P012 The effects of mesenchymal stem cells as a cell therapy in animal model of Crohn’s disease B.I. Jang1 *, W.Y. Jung2 , I.H. Song2 , K.O. Kim1 , C.H. Yang3 , G.A. Song4 . 1 Yeungnam University College of Medicine, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Daegu, Korea, Republic of, 2 Yeungnam University College of Medicine, Department of Anatomy, Daegu, Korea, Republic of, 3 Dongguk University College of Medicine, Division of gastroenterology and Hepatology, department of Internal Medicine, Kyungju, Korea, Republic of, 4 Pusan National University School of Medicine, and Biomedical Research Institute, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Busan, Korea, Republic of Background: Inflammatory bowel disease (IBD) is a complex immunological disease characterized by chronic inflammation with unknown cause. Interleukin-10 Knockout (IL-10 KO) mouse is a well-established murine model of IBD which develop a spontaneous intestinal inflammation that resemble with Crohn’s disease. In the present study, human adipocyte derived stem cells (hAMSC) were administrated to IL-10 KO mice to find out antiinflammatory effects of hAMSCs may attenuate progress or treat of IBD. Methods: IBD was induced in IL-10 KO mouse by feed piroxicam mixed diet for 1 week and then, 2×106 hAMSC were injected into peritoneum and changed to normal diet. After 1 week, the mice were sacrificed and tissue sample was harvested and tissue score for inflammation and inflammation related gene expression were evaluated. Results: hAMSC administrated group showed reduced inflammatory changes significantly. The effect was more powerful in ascending colon than descending or cecum in regional analysis. In categorical analysis, protection effect on chronic inflammation was more evident than acute inflammation considering ordinary progress of IBD; inflammatory cells appear, goblet cells change, mucosa thickening, submucosa cell infiltration, and destruction of architecture. RT-PCR analysis showed that Rantes, toll like receptor, IL-4 expression were not noticeably different between groups but IL-12, INF, TNF-a showed significant decrease in hAMSC group. Conclusions: hAMSC attenuate IBD induction in IL-10 KO mouse by suppression of inflammatory cytokine expression and this expected to be influenced through type 1 helper T cell pathway. Even though single injection of hAMSC, the effect influenced chronic event of inflammatory changes. These findings suggested that administration of hAMSCs show beneficial effect on animal model of CD and emerge a therapeutic option in inflammatory bowel disease. P013 The effects of Schistosoma japonicum eggs antigen on SAMP1/Yit mice, a spontaneous ileitis model T. Arai *, T. Seki, T. Kumagai, R. Shimogawara, N. Ohta. Graduate School of Tokyo Medical and Dental University, Department of Environmental Parasitology, Bunkyo-ku, Japan Background: It is known that the development of Crohn’s disease (CD) is related to a polarized Th1 response. Exposure to Schistosoma japonicum (SJ) eggs causes strong Th2 response, which is inhibitory against the Th1 response. Furthermore, it activates a network of regulatory T cells (Tregs) that secret interleukin-10. This cytokine down-regulate Th1 response in mice. Several studies showed that exposure to SJ eggs protected mice from experimental colitis. However, S70 these experiments have been conducted with drug induced models, such as 2, 4, 6-trinitrobenzene sulfonic acid (TNBS). Considering that drug induced models are artificial and affect large bowel rather than small intestine, it is not suitable for studies on CD. A senescence-accelerated mouse (SAM) P1/Yit is a strain that develop spontaneous ileitis with 100% penetrance until 30 weeks of age, while losing its senescence accelerated phenotype. In this study, we investigated that whether exposure to SJ eggs prevent spontaneous ileitis. Methods: Specific pathogen-free SAMP1/Yit mice were donated by the Yakult Central Institute for Microbiological Research (Tokyo, Japan). AKR/NSLc mice were used as control mice. SJ eggs were collected from the liver of Schistosome-infected mice. The eggs were washed in phosphate buffered saline (PBS). Mice were injected with freeze-killed 5,000 eggs intraperitoneally once a week from 12 to 29 weeks of age. Control mice received PBS with the same volume. The effects of SJ eggs were quantified as follows: 1) body weight loss, 2) histological score of microscopic inflammation of ileum, 3) cytokines profiles of T-lymphocytes which are isolated from mesenteric lymph nodes (MLN). Statistical analyses were performed using Student’s t test. P < 0.05 was considered to be statistically significant. Results: 1) SAMP1/Yit mice treatment with SJ eggs showed tendency to gain weight. 2) Histological score of ileitis was not modulated. 3) In the treatment group, the concentration of Interleukin (IL) 4 was increased significantly, however interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha were not decreased and IL-10 was not increased compared to the control group. Conclusions: This is the first report that investigated the effects of SJ eggs antigen on spontaneous ileitis model of CD. These findings suggest that treatment with SJ eggs did not attenuate ileitis, but increased body weight and the upregulation of IL-4 suggest the therapeutic potentials of the parasite antigen for CD. P014 The effect of the anti-TNFa adalimumab on the levels of angiogenic factors in mucosal cultures from patients with inflammatory bowel disease (IBD) andez-Contreras1 , A. Algaba2 , P.M. Linares1 *, M.E. Fern´ M. Chaparro1 , F. Bermejo2 , J.P. Gisbert1 . 1 Hospital Universitario de La Princesa, IP and CIBERehd, Gastroenterology Unit, Madrid, Spain, 2 Hospital Universitario de Fuenlabrada, Gastroenterology Unit, Fuenlabrada, Spain Background: Effectiveness of adalimumab (ADA) treatment could be related to the modification of different angiogenic proteins, including VEGFA, Ang1, Ang2 and their receptor Tie2. The aim of our study is to compare the concentrations of several angiogenic factors in colonic mucosa culture supernatant (MCS) in patients with IBD and matched controls and to analyze their modifications with the in vitro ADA addition to the culture. Methods: Prospective study in patients with IBD and nonIBD controls that underwent endoscopy. Duplicates of colonic mucosa samples from affected and non-affected mucosa from each IBD patient were obtained for comparison. Both were washed and then cultured at 37ºC in 5% CO2 medium under shaking for 24hours. In one duplicate, ADA was added up to a final concentration of 10 mg/mL prior to culture. MCS levels in AP were determined by ELISA. Endoscopic ulcerative colitis (UC) and Crohn’s disease (CD) activity was ascertained by Mayo sub-score and SES-CD indexes, respectively. Results: 28 patients with IBD (16 UC, 12 CD) and 21 controls were included. Mean age was 41±16 years, and 61% were women. The mean disease duration was 7±7 years. According Poster presentations to endoscopic activity, 36% of patient had quiescent, 32% mild, 28% moderate, and 4% severe activity. All angiogenic factors mean levels in MCS were higher in affected than in non-affected MCS; VEGFA (19.1±18.7 versus 8.7±10.5 pg/mL/mg) and Ang2 (21.3±15.7 versus 11.8±8.9 pg/mL/mg) (p < 0.05). There were no differences in MCS depending on endoscopic activity. Levels of VEGFA, Ang1 and Ang2 from the affected, and VEGFA and Tie2 from the non-affected mucosa, were lower when cultured with ADA than without it (Table 1). Table 1. Levels of angiogenic factors in MCS from IBD patients after culture VEGFA Ang1 Ang2 Tie2 Affected mucosa Affected mucosa + ADA p-value Nonaffected mucosa Nonaffected mucosa + ADA p-value 19.1±18.7 15.7±8.8 21.3±15.7 12.0±5.5 14.6±14.5 12.2±6.2 19.4±13.1 12.4±16.1 0.003 0.021 0.021 0.911 5.8±6.1 9.1±7.1 10.4±6.7 5.3±5.2 0.027 0.069 0.406 0.021 8.6±10.5 12.5±9.3 11.8±8.9 8.8±7.0 Concentrations are expressed in pg/mL per mg of tissue. In UC patients, VEGFA and Ang1, and all angiogenic factors MCS mean levels were lower in the affected-mucosa and non-affected mucosa, and in the non-affected mucosa when cultured with ADA, respectively (Table 2). Table 2. Levels of angiogenic factors in MCS from CD patients after culture VEGFA Ang1 Ang2 Tie2 Affected mucosa Affected mucosa + ADA p-value Nonaffected mucosa Nonaffected mucosa + ADA p-value 20.4±13.9 18.2±9.6 27.2±14.6 12.7±4.6 15.7±10.9 13.8±6.4 25.7±10.9 14.7±18.8 0.015 0.049 0.743 0.720 5.0±6.0 8.7±5.8 12.2±7.8 4.4±3.1 0.015 0.020 0.001 0.026 7.0±7.2 13.0±9.6 14.5±9.8 7.5±3.7 Concentrations are expressed in pg/mL per mg of tissue. In contrast, in CD patients there were no differences in MCS angiogenic factors levels and the addition of ADA to the culture. Conclusions: ADA might downregulate the production of angiogenic factors in MCS. ADA addition to mucosal cultures affects angiogenic factors levels in samples from patients with UC differently than in patients from CD. P015 The VEGFC/VEGFR3 pathway controls colitis associated cancer formation and progression through lymphangiogenesis and lymphatic endothelial VE-cadherin C. Tacconi *, S. D’Alessio, C. Correale, A. Gandelli, S. Vetrano, S. Danese. Humanitas Research Hospital, IBD Center, Rozzano, Milan, Italy Background: Chronic intestinal inflammation occurring in Inflammatory Bowel Disease (IBD) predisposes to colitisassociated colorectal cancer (CAC). Tumor-induced lymphangiogenesis is one of the processes taking place in cancer, but no mechanistic data is available on the molecules modulating lymphangiogenesis in CAC. VEGFC is a key player in lymphangiogenesis that signals through its cognate receptor VEGFR3 and its blockade has been used in several models of metastatic cancer. However, little is known about the role played by adherens’ junction proteins, such as Vascular Endothelial (VE)-cadherin, on the lymphatic endothelium during the metastatic process. We hypothesized that lymphaticstargeted therapy may be effective in CAC formation and would
© Copyright 2024 ExpyDoc